Characterization of PXR mediated P-glycoprotein regulation in intestinal LS174T cells

被引:35
作者
Kota, Bhavani Prasad [1 ]
Tran, Van H. [1 ]
Allen, John [2 ]
Bebawy, Mary [1 ]
Roufogalis, Basil D. [1 ]
机构
[1] Univ Sydney, Fac Pharm, Camperdown, NSW 2006, Australia
[2] Univ Sydney, Centenary Res Inst, Newtown, NSW 2042, Australia
基金
英国医学研究理事会;
关键词
Intestinal P-glycoprotein; Rifampicin; LS174T; Induction; Localization; Function; PREGNANE-X-RECEPTOR; RESISTANCE GENE-PRODUCT; MULTIDRUG-RESISTANCE; ABC-TRANSPORTERS; MDR1; EXPRESSION; DRUG TRANSPORT; IN-VITRO; INDUCTION; INHIBITION; CYP3A4;
D O I
10.1016/j.phrs.2010.07.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Intestinal P-glycoprotein (P-gp) is an important target in drug-drug interactions. Pregnane X receptor (PXR) mediates the induction of intestinal P-gp. The LS174T intestinal cell line has been used in several studies as an in vitro tool to identify the effect of PXR inducers on intestinal P-gp expression. In this study we aimed to further characterize this cell line by focusing on the time dependence of P-gp expression, localization and function in the presence of rifampicin, a P-gp inducer. P-gp protein expression was increased in a time and dose dependent manner following exposure of cells to rifampicin (5-50 mu M). The induction of P-gp by rifampicin and its inhibition by ketoconazole (an inhibitor of PXR mediated P-gp induction) confirms the suitability of these cells for PXR induction studies. Confocal microscopy showed that P-gp translocated from intracellular compartments to plasma membrane over 7 days in L5174T cells. P-gp function, as established by rhodamine 123 (Rh123) intracellular accumulation, correlated with increasing P-gp expression and plasma membrane localization over this period. Our data demonstrates that LS174T cells provide a suitable in vitro model to test for the effect of PXR inducers/inhibitors on P-gp induction, localization and function over this culture period. This model also has application for the screening of drug candidates for effects on oral bioavailability via effects on the subcellular distribution and trafficking of P-gp. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:426 / 431
页数:6
相关论文
共 37 条
[1]   The power of the pump: Mechanisms of action of P-glycoprotein (ABCB1) [J].
Ambudkar, SV ;
Kim, IW ;
Sauna, ZE .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (05) :392-400
[2]   P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: The influence of culturing conditions and drug exposure on P-gp expression levels [J].
Anderle, P ;
Niederer, E ;
Rubas, W ;
Hilgendorf, C ;
Spahn-Langguth, H ;
Wunderli-Allenspach, H ;
Merkle, HP ;
Langguth, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (06) :757-762
[3]   Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43
[4]   Antimalarial artemisinin drugs induce cytochrome p450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor [J].
Burk, O ;
Arnold, KA ;
Nussler, AK ;
Schaeffeler, E ;
Efimova, E ;
Avery, BA ;
Avery, MA ;
Fromm, MF ;
Eichelbaum, M .
MOLECULAR PHARMACOLOGY, 2005, 67 (06) :1954-1965
[5]   Lack of interactions between breast cancer resistance protein (BCRP/ABCG2) and selected antiepileptic agents [J].
Cerveny, L ;
Pavek, P ;
Malakova, J ;
Staud, F ;
Fendrich, Z .
EPILEPSIA, 2006, 47 (03) :461-468
[6]   Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions? [J].
Collett, A ;
Tanianis-Hughes, J ;
Warhurst, G .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (04) :783-790
[7]   EXPRESSION OF THE MULTIDRUG RESISTANCE GENE-PRODUCT (P-GLYCOPROTEIN) IN HUMAN NORMAL AND TUMOR-TISSUES [J].
CORDONCARDO, C ;
OBRIEN, JP ;
BOCCIA, J ;
CASALS, D ;
BERTINO, JR ;
MELAMED, MR .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (09) :1277-1287
[8]   Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4 [J].
Cummins, CL ;
Jacobsen, W ;
Benet, LZ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03) :1036-1045
[9]  
Engdal S, 2008, XENOBIOTICA, V38, P559, DOI [10.1080/00498250801986969, 10.1080/00498250801986969 ]
[10]   Inhibition of P-glycoprotein-mediated drug transport - A unifying mechanism to explain the interaction between digoxin and quinidine [J].
Fromm, MF ;
Kim, RB ;
Stein, CM ;
Wilkinson, GR ;
Roden, DM .
CIRCULATION, 1999, 99 (04) :552-557